US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
US4517288A
(en)
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4702909A
(en)
|
1982-05-05 |
1987-10-27 |
Louisiana State University A & M |
Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
|
CA1291031C
(en)
|
1985-12-23 |
1991-10-22 |
Nikolaas C.J. De Jaeger |
Method for the detection of specific binding agents and their correspondingbindable substances
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
US5118606A
(en)
|
1988-09-02 |
1992-06-02 |
The Regents Of The University Of California |
Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
|
US5234814A
(en)
*
|
1989-06-01 |
1993-08-10 |
Du Pont Merck Pharmaceutical Company |
Diagnostic assay for alzheimer's disease
|
US5118937A
(en)
|
1989-08-22 |
1992-06-02 |
Finnigan Mat Gmbh |
Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
|
US5045694A
(en)
|
1989-09-27 |
1991-09-03 |
The Rockefeller University |
Instrument and method for the laser desorption of ions in mass spectrometry
|
IE910713A1
(en)
|
1990-03-05 |
1991-09-11 |
Cephalon Inc |
Chymotrypsin-like proteases
|
US5586226A
(en)
|
1990-05-16 |
1996-12-17 |
Canon Kabushiki Kaisha |
Control method and device for a unicolor printer
|
US5637459A
(en)
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US5567588A
(en)
*
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
ES2259800T3
(es)
*
|
1990-06-11 |
2006-10-16 |
Gilead Sciences, Inc. |
Procedimientos de uso de ligandos de acido nucleico.
|
US5707796A
(en)
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US6011020A
(en)
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US5252463A
(en)
*
|
1990-06-22 |
1993-10-12 |
The Du Pont Merck Pharmaceutical Company |
Clipsin, a chymotrypsin-like protease and method of using same
|
AU2414092A
(en)
|
1991-08-01 |
1993-03-02 |
Paul H. Voorheis |
Diagnostic method for alzheimer's disease
|
US5792664A
(en)
|
1992-05-29 |
1998-08-11 |
The Rockefeller University |
Methods for producing and analyzing biopolymer ladders
|
DE69334274D1
(de)
|
1992-05-29 |
2009-05-14 |
Univ Rockefeller |
Verfahren zur Bestimmung der Folge von Peptiden unter Verwendung eines Massenspektrometers
|
ES2201077T3
(es)
|
1993-05-28 |
2004-03-16 |
Baylor College Of Medicine |
Metodo y espectrometro de masas para la desorcion e ionizacion de analitos.
|
DE4337654C2
(de)
|
1993-11-04 |
1996-08-08 |
Biotest Pharma Gmbh |
Verwendung boviner Kolostralmilch von nicht mit Viren hyperimmunisierten Tieren als Leberschutzpräparat
|
US5536639A
(en)
|
1994-03-25 |
1996-07-16 |
Cephalon, Inc. |
Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
|
JP4429385B2
(ja)
*
|
1994-07-15 |
2010-03-10 |
セフアロン・インコーポレーテツド |
バキュロウイルスにより発現される活性カルパイン
|
US5614649A
(en)
|
1994-11-14 |
1997-03-25 |
Cephalon, Inc. |
Multicatalytic protease inhibitors
|
US5777194A
(en)
*
|
1995-04-26 |
1998-07-07 |
Cephalon, Inc. |
Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation
|
AU712180B2
(en)
|
1996-02-02 |
1999-10-28 |
Argutus Intellectual Properties Limited |
Method of determining the hepatic status of an individual, including a liver transplant recipient
|
US6048703A
(en)
|
1996-11-15 |
2000-04-11 |
Cephalon, Inc. |
Methods for detecting cell apoptosis
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
EP1037626A1
(en)
|
1997-12-16 |
2000-09-27 |
Cephalon, Inc. |
Multicatalytic protease inhibitors for use as anti-tumor agents
|
WO1999051773A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
CA2340433A1
(en)
|
1998-09-08 |
2000-03-16 |
Innogenetics N.V. |
Tau as a marker for early cns damage
|
WO2000056934A1
(en)
|
1999-03-24 |
2000-09-28 |
Packard Bioscience Company |
Continuous porous matrix arrays
|
US6218005B1
(en)
*
|
1999-04-01 |
2001-04-17 |
3M Innovative Properties Company |
Tapes for heat sealing substrates
|
US20020002270A1
(en)
|
1999-06-16 |
2002-01-03 |
Raymond P. Zinkowski |
Purified antigen for alzheimer's disease, and methods of obtaining and using same
|
US6589746B1
(en)
|
1999-10-21 |
2003-07-08 |
University Of Cincinnati |
Method of detecting axonally-derived protein tau in patients with traumatic CNS injury
|
US6664442B2
(en)
*
|
2000-03-30 |
2003-12-16 |
Elan Pharmaceuticals, Inc. |
Selecting compounds to reduce inflammation associated with Alzheimer's disease
|
US20050063942A1
(en)
|
2001-02-02 |
2005-03-24 |
Clark Mike A. |
Methods for predicting sensitivity of tumors to arginine deprivation
|
US6949377B2
(en)
|
2001-03-05 |
2005-09-27 |
Ho Winston Z |
Chemiluminescence-based microfluidic biochip
|
US20030199000A1
(en)
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040253637A1
(en)
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US7713705B2
(en)
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US20040203083A1
(en)
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
US20020172676A1
(en)
|
2001-05-16 |
2002-11-21 |
George Jackowski |
Method of treatment of alzheimer's disease and device therefor
|
US7144708B2
(en)
|
2001-06-25 |
2006-12-05 |
The Cleveland Clinic Foundation |
Markers of blood barrier disruption and methods of using same
|
JP2003070498A
(ja)
|
2001-07-19 |
2003-03-11 |
Pharma Design Inc |
ユビキチンカルボキシルターミナルヒドロラーゼl1遺伝子異常の検出方法
|
JP2005522669A
(ja)
*
|
2001-08-20 |
2005-07-28 |
バイオサイト インコーポレイテッド |
卒中および脳損傷の診断マーカーおよびその使用方法
|
US20030040660A1
(en)
|
2001-08-27 |
2003-02-27 |
George Jackowski |
Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
|
WO2003032894A2
(en)
|
2001-10-12 |
2003-04-24 |
Pfizer Products Inc. |
Method of monitoring neuroprotective treatment
|
US7371582B2
(en)
|
2002-01-23 |
2008-05-13 |
Boditechmed Inc. |
Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor
|
EP1476747A4
(en)
|
2002-01-31 |
2008-06-11 |
Ocimum Biosolutions Inc |
MOLECULAR HEPATOTOXICOLOGICAL MODELING
|
EP1495419A2
(en)
|
2002-04-01 |
2005-01-12 |
Phase-1 Molecular Toxicology Inc. |
Liver necrosis predictive genes
|
WO2004078204A1
(en)
|
2002-06-12 |
2004-09-16 |
The Cleveland Clinic Foundation |
Markers of blood barrier permeability and methods of using same
|
WO2004025298A1
(en)
|
2002-09-11 |
2004-03-25 |
University Of Florida |
Analyzing nerve cell damage
|
JP2006526140A
(ja)
|
2002-12-24 |
2006-11-16 |
バイオサイト インコーポレイテッド |
鑑別診断のためのマーカーおよびその使用方法
|
EP1635763B1
(en)
|
2003-06-09 |
2012-08-08 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
EP2357477B1
(en)
|
2003-09-20 |
2017-11-08 |
Electrophoretics Limited |
Diagnostic method for brain damage-related disorders based on the detection of NDKA
|
GB0322063D0
(en)
*
|
2003-09-20 |
2003-10-22 |
Univ Geneve |
Diagnostic method for brain damage-related disorders
|
EP1519194A1
(en)
*
|
2003-09-24 |
2005-03-30 |
Roche Diagnostics GmbH |
Use of gfap for identification of intracerebral hemorrhage
|
US20050130226A1
(en)
|
2003-09-26 |
2005-06-16 |
The University Of Cincinnati |
Fully integrated protein lab-on-a-chip with smart microfluidics for spot array generation
|
EP2369348A1
(en)
|
2003-11-07 |
2011-09-28 |
Ciphergen Biosystems, Inc. |
Biomarkers for Alzheimer's disease
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
US20050112585A1
(en)
|
2003-11-21 |
2005-05-26 |
Dominic Zichi |
Method for adjusting the quantification range of individual analytes in a multiplexed assay
|
TWI281473B
(en)
|
2003-12-19 |
2007-05-21 |
Ind Tech Res Inst |
Biomarkers for liver diseases and method for using same
|
CA2834041C
(en)
|
2003-12-31 |
2017-05-16 |
President And Fellows Of Harvard College |
Assay device and method
|
US20140303041A1
(en)
|
2004-04-15 |
2014-10-09 |
University Of Florida Research Foundation Inc. |
In vitro diagnostic devices for nervous system injury and other neural disorders
|
EP2207033B1
(en)
*
|
2004-04-15 |
2014-06-18 |
University of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
AU2005245785B2
(en)
|
2004-04-15 |
2011-04-07 |
Banyan Biomarkers Inc. |
Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
|
US8492107B2
(en)
|
2004-04-15 |
2013-07-23 |
University Of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
US20060292558A1
(en)
|
2004-07-19 |
2006-12-28 |
Cell Biosciences Inc. |
Methods and apparatus for protein assay diagnostics
|
EP1796838B1
(de)
|
2004-10-15 |
2014-10-08 |
Boehringer Ingelheim Vetmedica GmbH |
Verfahren zur durchführung einer elektrochemischen messung an einer flüssigen messprobe in einer über leitungen zugänglichen messkammer
|
WO2006107846A2
(en)
|
2005-04-01 |
2006-10-12 |
University Of Florida Research Foundation, Inc. |
Biomakers of liver injury
|
US8048638B2
(en)
|
2005-04-01 |
2011-11-01 |
University Of Florida Research Foundation, Inc. |
Biomarkers of liver injury
|
GB2428240A
(en)
|
2005-07-14 |
2007-01-24 |
Univ Gen Ve |
Diagnostic method for brain damage-related disorders
|
EP1938101A2
(en)
|
2005-09-13 |
2008-07-02 |
Fluidigm Corporation |
Microfluidic assay devices and methods
|
EP1949103A2
(en)
|
2005-10-20 |
2008-07-30 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
WO2007079530A1
(en)
|
2006-01-12 |
2007-07-19 |
Mycrolab Pty Ltd |
New instrumentation systems and methods
|
US8563291B2
(en)
|
2006-02-15 |
2013-10-22 |
Mie University |
Method of constructing recombinant proteoliposome for diagnostic use
|
US20070255113A1
(en)
|
2006-05-01 |
2007-11-01 |
Grimes F R |
Methods and apparatus for identifying disease status using biomarkers
|
WO2007136617A2
(en)
|
2006-05-18 |
2007-11-29 |
Walter Reed Army Institute Of Research (Wrair) |
Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
|
WO2007140188A2
(en)
|
2006-05-26 |
2007-12-06 |
Biosite Incorporated |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
WO2008008819A2
(en)
|
2006-07-11 |
2008-01-17 |
University Of Florida Research Foundation, Inc. |
Diagnosis and treatment of neurological inflammation
|
EP2097094A4
(en)
|
2006-11-01 |
2011-01-05 |
George Mason Intellectual Prop |
BIOMARKERS FOR NEUROLOGICAL SUFFERING
|
WO2008095136A2
(en)
|
2007-01-31 |
2008-08-07 |
Henkin Robert I |
Methods for detection of biological substances
|
WO2008097618A1
(en)
|
2007-02-06 |
2008-08-14 |
University Of Florida Research Foundation, Inc. |
Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
|
US20120196307A1
(en)
|
2007-02-06 |
2012-08-02 |
Banyan Biomarkers, Inc. |
Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
|
CA2715248A1
(en)
|
2008-02-04 |
2009-08-13 |
Banyan Biomarkers, Inc. |
Process to diagnose or treat brain injury
|
AU2009236057B2
(en)
|
2008-04-17 |
2015-05-07 |
Banyan Biomarkers, Inc. |
An antibody bound synthetic vesicle containing active agent molecules
|
EP2143735A1
(en)
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
EP3336551B1
(en)
|
2008-08-11 |
2023-05-31 |
Banyan Biomarkers, Inc. |
Biomarker detection process and assay of neurological condition
|
US20140342381A1
(en)
|
2008-08-11 |
2014-11-20 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of neurological condition
|
US8642558B2
(en)
|
2008-09-19 |
2014-02-04 |
Henry Ford Health Systems |
Methods, systems, and compositions for calpain inhabition
|
US20120094295A1
(en)
|
2008-11-21 |
2012-04-19 |
The Johns Hopkins University |
Neurodegenerative disease diagnostic compositions and methods of use
|
US20170315136A9
(en)
|
2009-06-19 |
2017-11-02 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
WO2010148391A2
(en)
|
2009-06-19 |
2010-12-23 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
WO2011011334A2
(en)
|
2009-07-18 |
2011-01-27 |
Banyan Biomarkers, Inc. |
SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β
|
WO2011032155A2
(en)
|
2009-09-14 |
2011-03-17 |
Banyan Biomarkers, Inc. |
Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
|
CA2784919A1
(en)
|
2010-01-26 |
2011-07-26 |
Banyan Biomarkers, Inc. |
Compositions and methods relating to argininosuccinate synthetase
|
EP2553466A4
(en)
|
2010-04-01 |
2013-10-16 |
Banyan Biomarkers Inc |
MARKERS AND ASSAYS FOR DETECTING NEUROTOXICITY
|
WO2011160096A2
(en)
|
2010-06-17 |
2011-12-22 |
Banyan Biomarkers, Inc. |
Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
|
EP2628013B1
(en)
|
2010-10-14 |
2019-06-12 |
The Johns Hopkins University |
Biomarkers of brain injury
|
CN103959067B
(zh)
|
2011-09-14 |
2018-04-24 |
促进军事医学的亨利·M·杰克逊基金会公司 |
用于检测和监测用于创伤后应激障碍(ptsd)的诊断生物标志物以及用于区分自杀式与非自杀式障碍的试剂盒
|
US20140018299A1
(en)
|
2012-07-10 |
2014-01-16 |
Banyan Biomarkers, Inc. |
Method and device to detect, monitor and promote neural regeneration and improvement of cognitive function in a subject suffering from neural injury
|
US20140024053A1
(en)
|
2012-07-20 |
2014-01-23 |
Banyan Biomarkers, Inc. |
Methods, kits and devices for detecting bii-spectrin, and breakdown products thereof, as biomarkers for the diagnosis of neural injury
|
US20140275294A1
(en)
|
2013-03-15 |
2014-09-18 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of liver injury
|
US20150141528A1
(en)
|
2013-05-31 |
2015-05-21 |
Banyan Biomarkers, Inc. |
Neural specific s100b for biomarker assays and devices for detection of a neurological condition
|
EP3129780A4
(en)
|
2014-04-07 |
2017-12-13 |
Iron Horse Diagnostics Inc. |
Traumatic brain injury and neurodegenerative biomarkers, methods, and systems
|
EP3663764B1
(en)
|
2014-04-08 |
2023-11-01 |
University of Florida Research Foundation, Inc. |
Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system
|
US11078298B2
(en)
|
2016-10-28 |
2021-08-03 |
Banyan Biomarkers, Inc. |
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
|
WO2018191531A1
(en)
*
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
BR112019022476A2
(pt)
*
|
2017-04-28 |
2020-05-12 |
Abbott Laboratories |
Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano
|
JP7269182B2
(ja)
*
|
2017-05-30 |
2023-05-08 |
アボット・ラボラトリーズ |
心臓トロポニンi及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
|
WO2019113525A2
(en)
*
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
AU2018378084A1
(en)
*
|
2017-12-09 |
2020-05-14 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|